Baseline neutrophil-to-lymphocyte ratio as a predictive and prognostic biomarker in patients with metastatic castration-resistant prostate cancer treated with cabazitaxel versus abiraterone or enzalutamide in the CARD study

  1. de Wit, R.
  2. Wülfing, C.
  3. Castellano, D.
  4. Kramer, G.
  5. Eymard, J.-C.
  6. Sternberg, C.N.
  7. Fizazi, K.
  8. Tombal, B.
  9. Bamias, A.
  10. Carles, J.
  11. Iacovelli, R.
  12. Melichar, B.
  13. Sverrisdóttir, Á.
  14. Theodore, C.
  15. Feyerabend, S.
  16. Helissey, C.
  17. Foster, M.C.
  18. Ozatilgan, A.
  19. Geffriaud-Ricouard, C.
  20. de Bono, J.
Journal:
ESMO Open

ISSN: 2059-7029

Year of publication: 2021

Volume: 6

Issue: 5

Type: Article

DOI: 10.1016/J.ESMOOP.2021.100241 GOOGLE SCHOLAR lock_openOpen access editor